Barry L. Smith, MD

Article

Candida Esophagitis Associated With Adalimumab for Hidradenitis Suppurativa

Author:: Roya S. Nazarian, MD; Aaron S. Farberg, MD; Barry L. Smith, MD

There is risk for opportunistic infections with adalimumab, and patients should be monitored closely.

Read More

Article

Novel Psoriasis Therapies and Patient Outcomes, Part 3: Systemic Medications

Author:: Meghan A. Feely, MD; Barry L. Smith, MD; Jeffrey M. Weinberg, MD

The therapeutic armamentarium for patients with psoriasis and psoriatic arthritis (PsA) has been strengthened by research affording more...

Read More

Article

Novel Psoriasis Therapies and Patient Outcomes, Part 2: Biologic Treatments

Author:: Meghan A. Feely, MD; Barry L. Smith, MD; Jeffrey M. Weinberg, MD

Biologic treatments have revolutionized the management of psoriasis and psoriatic arthritis (PsA). Anti–tumor necrosis factor (TNF) α monoclonal...

Read More

Article

Novel Psoriasis Therapies and Patient Outcomes, Part 1: Topical Medications

Author:: Meghan A. Feely, MD; Barry L. Smith, MD; Jeffrey M. Weinberg, MD

In recent years, advances in our understanding of inflammatory mediators and the underlying pathogenesis of psoriasis and psoriatic arthritis have...

Read More

Article

What Is Your Diagnosis? Subacute Cutaneous Lupus Erythematosus

Author:: Maryann Mikhail, MD; Barry L. Smith, MD

A 41-year-old man has a mildly pruritic rash spanning the central portion of the chest that has been present and unchanged for approximately 9...

Read More